Updates from Merck (MSD)
Merck is a research-intensive biopharmaceutical company developing innovative medicines and vaccines to save and improve lives globally.
- Merck Receives Positive EU CHMP Opinion to Expand Marketing Authorization for ENFLONSIA® (clesrovimab) (Achievement · November 13, 2026)
The European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion on extending the use of ENFLONSIA to children up to 24 months old who are at risk for severe… - Merck Foundation Launches Community Collaborative for Reimagining HIV Care (Project update · July 16, 2026)
The Merck Foundation introduced a new initiative to improve access to high-quality HIV care across various communities in the United States.